This article discusses the retiring of Ph. Eur. and USP heavy metal assays as well as a means of updating related specifications with minimal regulatory burden.
Shoreh Shabrang
Advertisement
Shoreh Shabrang is senior consultant RA CMC, SAABAS LLC.
Articles by Shoreh Shabrang
The authors support the retiring of Ph. Eur. and USP heavy metal assays and propose a means of updating related specifications with minimal regulatory burden.
Advertisement
Latest Updated Articles
Pharma Collaboration Proposes Retirement of Obsolete Heavy Metals TestsPublished: September 1st 2018 | Updated:
- Retirement for Obsolete Heavy Metals Tests
Published: October 3rd 2018 | Updated:
Advertisement
Advertisement
Trending on Pharmaceutical Technology
1
Why Investment Strategies Matter for Advancing Pharmaceutical Technologies
2
New Dosage Forms and Delivery Systems Driving 505(b)(2) Success
3
PharmTech Weekly News Roundup – Week of November 3, 2025
4
AAPS PharmSci 360: Enhancing Bioanalysis with AI and Other Technologies
5
